Tag: Vaccine development

Browse exclusive Tags!

Potential Malaria Breakthrough: New Vaccine Shows 78% Efficacy, Ready for Roll-Out, Burkina Faso

New malaria vaccine with 78% efficacy in children ready to combat the deadly disease in Africa, potentially reducing transmission.

Indian Covid-19 Variant on the Rise Again, Raises Fear and Urges Precaution

Beware of the rising Indian Covid-19 variant. Governments issue warnings and urge precautionary measures. Learn from past mistakes and stay safe.

New AI Tool Predicts Future Viral Variants, Boosting Vaccine Development, US

Revolutionize vaccine development with the AI tool EVEscape. Predict future viral variants for more effective vaccines. Groundbreaking research from Harvard and Oxford.

HilleVax Plans $100M Public Offering to Advance Novel Vaccine Development

HilleVax announces $100M public offering to accelerate development of HIL-214 vaccine for norovirus-induced gastroenteritis. Learn more about their mission to improve global health outcomes.

Popular

New FDA-approved drug shields infants and toddlers worldwide against RSV

FDA approves first long-acting drug to protect babies and toddlers from RSV. Important step in reducing impact of severe RSV disease. Learn more!

Study Reveals Common Cold Coronaviruses May Contribute to Immunity Against COVID-19, Nigeria

New study suggests exposure to common cold coronaviruses may provide pre-existing immunity to COVID-19. Important implications for vaccine development and pandemic preparedness.

India Unveils First Omicron Booster Vaccine Against COVID-19 Variants

India's first Omicron booster vaccine, GEMCOVAC® -OM, has been launched. Developed by Gennova, with funding support from DBT and BIRAC, this unique mRNA-based vaccine can be administered without an injection and does not require ultra-cold chain infrastructure. It has received Emergency Use Authorization and is a thermostable vaccine that can be deployed to remote locations. With its future-ready technology platform, India is committed to fighting the COVID-19 pandemic.

New AI Tool Predicts Future Viral Variants, Boosting Vaccine Development, US

Revolutionize vaccine development with the AI tool EVEscape. Predict future viral variants for more effective vaccines. Groundbreaking research from Harvard and Oxford.

Subscribe

spot_imgspot_img